Avinger (NASDAQ:AVGR) Coverage Initiated by Analysts at StockNews.com

Equities research analysts at StockNews.com initiated coverage on shares of Avinger (NASDAQ:AVGR) in a report released on Sunday. The firm set a “hold” rating on the medical device company’s stock.

Avinger Stock Performance

Avinger stock opened at $0.47 on Friday. The business’s 50 day simple moving average is $0.64 and its 200 day simple moving average is $0.82. Avinger has a 12 month low of $0.36 and a 12 month high of $4.37. The company has a market cap of $1.57 million, a price-to-earnings ratio of -0.04 and a beta of 1.09.

About Avinger

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.